Data / Form D filings / Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc.: Form D filings
Dewpoint Therapeutics, Inc., a biotechnology company in Boston, MA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on July 13, 2026, reports $77.2 million sold of a $82.3 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 451 D STREET, SUITE 104, Boston, MA, 02210
- Phone
- (617) 914-8448
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1828893
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Amendment | $82,299,400 | $77,164,102 | $5,135,298 | 23 | Sep 9, 2025 | sec.gov |
| Sep 23, 2025 | New notice | $59,124,298 | $59,124,298 | 21 | Sep 9, 2025 | sec.gov | |
| Feb 4, 2022 | New notice | $149,999,989 | $149,999,989 | 18 | Jan 26, 2022 | sec.gov | |
| Nov 2, 2020 | New notice | $77,097,477 | $77,097,477 | 25 | Jul 7, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ameet Nathwani, M.D. | Executive Officer, Director | |
| Srinivas Akkaraju, M.D., Ph.D. | Director | |
| Regina Barzilay, Ph.D. | Director | |
| Olivier Brandicourt, M.D. | Director | |
| Giuseppe A. Ciaramella, Ph.D. | Director | |
| Anthony A. Hyman, Ph.D. | Director | |
| Mark Murcko, Ph.D. | Director | |
| Amir H. Nashat, Sc.D. | Director | |
| Steven Neier, Ph.D. | Director | |
| Richard A. Young, Ph.D. | Director | |
| Isaac A. Klein, M.D., Ph.D. | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 13, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Dewpoint Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.